Phase II Exploratory Study of Sequential Triple Therapy (Temozolomide/Anlotinib/Bemarituzumab) in Combination With Concurrent Radiotherapy With Temozolomide and Anlotinib for the Maintenance Treatment of Diffuse Midline Gliomas in Children
Clinical trial NCT07020052 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07020052
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-10
- Primary completion
- 2030-04-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.